Navigation Links
Celsion Reports Third Quarter 2010 Financial Results and Provides Business Update
Date:11/15/2010

er of 2010, Celsion recorded as other income a $0.5 million non-cash benefit related to a mark-to-market change in the common stock warrant liability related to the stock offering completed in September 2009.  In the first nine months of 2010, Celsion recorded a $0.7 million non-cash benefit related to the change in the common stock warrant liability.  In the same period of 2009, the Company recorded a non-cash indemnity reserve benefit of $1.1 million related to the sale of its medical device business in 2007, which reduced general and administrative expenses in the nine month prior year period.

The Company ended the third quarter with $3.2 million of cash and investments.  In September 2010, the Company raised $1.4 million from two draws under its June 2010 Committed Equity Financing Facility.  The proceeds will be used to accelerate commercial manufacturing activities for ThermoDox®.  On November 1, 2010, the Company was awarded a $244,000 grant under the Qualifying Therapeutic Discovery Project (QTDP) program under The Patient Protection and Affordable Care Act of 2010. This maximum grant amount for a single program was awarded to Celsion for its Thermodox® clinical development program.

Recent Business Highlights

  • Patient enrollment for the Phase III HEAT study to date is approaching 80% completion.  Efforts to stimulate patient enrollment continue with full enrollment expected in the first quarter of 2011;
  • The Committee for Orphan Medicinal Products of the European Medicines Agency (EMA) issued a positive opinion on the Company's application for Orphan Drug Designation for ThermoDox® for the treatment of HCC;
  • The Independent Data Monitoring Committee unanimously recommended continuation of the Phase III HEAT study to treat Primary Liver Cancer after review of 401 patients enrolled in the trial;
  • Fast Track designation received for ThermoDox® development program
    '/>"/>

  • SOURCE Celsion Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Celsion Announces Date and Time Change for Third Quarter 2010 Financial Results Conference Call to Monday, November 15, 2010
    2. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
    3. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
    4. Par Pharmaceutical Reports Second Quarter 2008 Results
    5. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
    6. Pharmos Corporation Reports 2008 Second Quarter Results
    7. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
    8. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
    9. BMP Sunstone Reports Second Quarter 2008 Financial Results
    10. ULURU Inc. Reports Second Quarter 2008 Financial Results
    11. Immtech Reports Fiscal First Quarter 2009 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/10/2014)... According to the International Atomic Energy Agency (IAEA) ... terrorists acquiring sufficient quantities of plutonium or highly ... explosive device. The IAEA also notes that most ... quantities, which can be challenging to detect with ... study appearing this week in the Journal ...
    (Date:7/10/2014)... today in the journal PNAS (Proceedings of the ... of day and sleep deprivation have a significant effect ... looking at the best time of day to test ... for administering medicines effectively. , Researchers from the University ... investigated the links between sleep deprivation, body clock disruption ...
    (Date:7/10/2014)... Wash. The lithium-ion batteries that power our laptops ... longer on a single charge with the help of ... porous material to replace the graphite traditionally used in ... than 10 times the energy storage capacity of graphite. ... battery electrode was published today in Nature Communications ...
    (Date:7/10/2014)... recent study by researchers at the University of ... physical mechanisms governing the interplay of spin and ... limits of ultrafast spintronic devices for data storage ... charge as well as spin-angular momentum. In a ... there is no spin current," explained David Cahill, ...
    Breaking Biology Technology:Sensitive detection method may help impede illicit nuclear trafficking 2Time of day crucial to accurately test for diseases, new research finds 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3University of Illinois study advances limits for ultrafast nano-devices 2
    ... ... stick that can be shipped from stock greatly minimizing lead times for Semiconductor tool ... (PRWEB) ... specializing in process controls for the delivery of critical fluids, introduces an innovation to ...
    ... , PLEASANTON, Calif., FRAMINGHAM, Mass. ... THOR ), a world leader in device-based mechanical circulatory support ... International, Inc. (Nasdaq: HTWR ; ASX: HIN), which ... the United States Federal Trade Commission ("FTC") has informed them ...
    ... , , BETHESDA, Md., July ... company developing novel, proprietary antibodies for the treatment of cancer, inflammation ... of its common stock in a public offering. Piper Jaffray & ... Capital Markets as co-manager in this offering. The offering is ...
    Cached Biology Technology:Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 2Aztech Controls Introduces Standardized Gas Sticks for Semiconductor Tool Hook Up 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 2U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 3U.S. Federal Trade Commission to Challenge Thoratec's Proposed Acquisition of HeartWare International 4Micromet Announces Public Offering of Common Stock 2Micromet Announces Public Offering of Common Stock 3Micromet Announces Public Offering of Common Stock 4
    (Date:7/11/2014)... July 11, 2014 Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
    (Date:7/11/2014)... hippocampus, the marginal division of the striatum is ... the impact degree of substance P in the ... Yan Yu and his team, College of Biophotonics, ... staining, that substance P receptor, neurokinin 1 was ... division of normal rats. Unilateral or bilateral injection ...
    (Date:7/11/2014)... , July 11, 2014 Research and ... "International Biometrics Technology Market - Industry Analysis Size Share ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... crimes has created a need for high level security ... for personnel authentication such as username and passwords, tokens ...
    Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
    ... Prof. Makoto Tominaga and Dr. Takaaki Sokabe (National Institute ... in skin keratinocytes is important for formation and maintenance ... reported in the Journal of Biological Chemistry. ... namely "thermoTRPs". It is expressed in skin, acting as ...
    ... -- Astronauts are known to have a higher risk of ... go with weightlessness, confined crew quarters, being away from family ... while not getting enough sleep - are known to wreak ... by immunobiologist Ty Lebsack at the University of Arizona has ...
    ... same digital technology that enables young people to play video ... a simulated coral reef environment where they participate in science ... Field Museum scientists will link students from Chicago,s Austin neighborhood ... the Pacific Ocean, engage in the scientific process, and participate ...
    Cached Biology News:Immune system compromised during spaceflight, study finds 2Immune system compromised during spaceflight, study finds 3Field Museum technology project wins prestigious award 2
    Cytidine 5'-Triphosphate, Sodium (CTP), 1 g. Category: Nucleotides & Enzymes & Biochemicals, Nucleotides, Additional Nucleotide Products....
    biotin-4-fluorescein...
    ... Consists of the LVF-HL, LVF-CUVADPT, FHS-LVF, and ... high-pass and low-pass Linear Variable Filters to ... an adjustable center wavelength and adjustable bandpass. ... (~90%) and blocking band (99.8%). These ...
    BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
    Biology Products: